The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced ...
Neither drug is considered as effective as the brand ... requiring treatment for type 2 diabetes," Cody Stanford said. The list price for Ozempic and Mounjaro each run more than $1,000 a month ...